Another study indicates that Belimumab treatment significantly reduces immature B-cell subpopulations in SS and normalizes BAFF-R (BAFF receptor) expression across all B-cell subpopulations (156). This evidence concerns the gene TNFRSF13C and synovial sarcoma.